Inhalable human ACE2-containing nanocatchers may protect host cells from SARS-CoV-2 infection July 27, 2021
Responses seen with personalized neoantigen peptide vaccine in NSCLC patients with EGFR mutations July 27, 2021
Leo Pharma begins phase IIa study of LEO-138559 for moderate to severe atopic dermatitis July 27, 2021
RSS